Should Surgical Resection Be Combined with Imatinib Therapy for Locally Advanced or Metastatic Gastrointestinal Stromal Tumors?

By Yoon Sam   Tanabe Kenneth  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1784-1786

Springer Publishing Company

Access to resources Recommend Favorite

Surgical debulking of gastrointestinal stromal tumors: Is it a reasonable option after second-line treatment with sunitinib?

By Pantaleo M.   Di Battista M.   Catena F.   Astorino M.   Saponara M.   Di Scioscio V.   Santini D.   Piazzi G.   Castellucci P.   Brandi G.   Biasco G.  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 625-630

Springer Publishing Company

Access to resources Recommend Favorite

Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy

By Hasegawa Junichi   Kanda Tatsuo   Hirota Seiichi   Fukuda Masafumi   Nishitani Akiko   Takahashi Tsuyoshi   Kurosaki Isao   Tsutsui Shusaku   Hatakeyama Katsuyoshi   Nishida Toshirou  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 212-217

Springer Publishing Company

Access to resources Recommend Favorite

Transsacral excision with preoperative imatinib mesylate treatment and approach for gastrointestinal stromal tumors in the rectum: A report of two cases

By                  

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1455-1460

Spandidos Publications

Access to resources Recommend Favorite

Surgical Management After Neoadjuvant Imatinib Therapy in Gastrointestinal Stromal Tumours (GISTs) with Respect to Imatinib Resistance Caused by Secondary KIT Mutations

By Haller Florian   Detken Sven   Schulten Hans-Jürgen   Happel Nicole   Gunawan Bastian   Kuhlgatz Jens   Füzesi László  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 526-532

Springer Publishing Company

Access to resources Recommend Favorite